Press Releases from mivenion GmbH (6 total)
mivenion receives market authorization for Xiralite® in Canada
Fluorescence optical imaging (FOI) with the Xiralite® fluorescence imaging system X4 is a sensitive and safe medical procedure for visualization of altered microcirculation in the…
mivenion announces 4 abstracts for fluorescence optical imaging using the Xirali …
Highlights include:
• ICG-enhanced fluorescence optical imaging (FOI) is able to detect typical inflammatory changes in subjects with arthralgia and psoriasis prior to signs of clinically…
mivenion to establish Rheumascan at Karolinska Institutet, Stockholm, Sweden
About 5% of the patients attending primary care physicians intermittently suffer from swelling and tenderness of the hand joints. In many cases, inflammatory joint diseases…
mivenion receives ISO 13485 certification for Xiralite® manufacturing and distr …
mivenion has received the official ISO 13485:2003 + AC:2009 certification as a medical device manufacturer. Published in 2003, the ISO 13485 standard outlines the requirements…
mivenion GmbH and PTB Berlin report patent grants for imaging of inflammation
mivenion GmbH announces that it has secured patent protection for its key technology of optical imaging of inflammation. The patent rights covering diagnostic technologies for…
mivenion targets musculoskeletal imaging experts at ECR 2011
mivenion GmbH, the leading company in optical imaging of arthritis, will exhibit its groundbreaking Rheumascan workstation Xiralite® X4 and the most advanced XiraView…
Go To Page:
